Surgical technique involved the use of a limbal-based conjunctival flap and MMC 0.2 mglml applied via a sponge (under the scleral flap) to both scleral and conjunctival surfaces for 5 minutes. The mean follow up period was 12.7 months (range 3-24). There were 17 successful eyes. Of these, 14 are high pressure glaucoma eyes with a mean pre-operative lOP of 30.9 ± 10.9 mmHg and a mean postoperative lOP of 15.3 ± 5.2 mmHg (p = 0.001). The remainder of the successful cases include 4 patients with LTG with a mean pre operative lOP of 17.8 ± 0.5 mmHg and a mean post operative lOP of 6.8 ± 0.7 mmHg (p = 0.001). Serious complications included chronic repeated bleb leaks (n = 2) and scleral necrosis (n = 2). There was one case of hypotonous maculopathy. These results are compar able with those of other studies. Despite a relatively low dose of MMC serious side-effects were encountered.
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Management of these complications is described, and how these effects may be prevented by altering scleral exposure to MMC. In addition a possible explanation for the serious side-effects of MMC-treated trabeculec tomies is presented.
Failure of glaucoma filtration surgery can be attributed to excessive healing under the Tenon's/ conjunctival lamina. The major cellular component responsible for this reaction is thought to be fibroblasts derived from local tissues. 1 , 2 Although
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Mitomycin C (MMC) was first used in ophthalmol ogy post-operatively in a topical form after pter ygium surgery to prevent recurrence of this condition ? This drug is an antibiotic originally isolated in Japan in 1954 from the broth of a fungus Streptomyces caespitosus and has anti-tumour activity due to its alkylating effects preventing DNA synthesis. 4 MMC has also been shown to inhibit Tenon's capsule/conjunctival fibroblast proliferation in vitro using cell culture techniques.s-8 This latter effect of MMC has been applied in vivo to modify the healing response after glaucoma filtration surgery in eyes regarded as high-risk cases, such as eyes that have undergone previous failed glaucoma surgery, aphakic eyes, black or Asian eyes and eyes of patients requiring very low intraocular pressure. 9 -1 6 These studies have used a wide variation in the concentration and exposure duration of MMC employed for filtration surgery. This series addresses the surgical success rate and complications of trabeculectomy using 0.2 mg/ml MMC.
PATIENTS AND METHODS
We looked at a consecutive series of 20 eyes from 18 patients that have undergone glaucoma filtration surgery using MMC as an adjunct. The mean follow up period was 12.7 months (range 3-24 months). There were 7 men and 11 women and all are Caucasian. The average age was 64.5 years (range 36-92 years). Sixteen patients in this study were considered as high risk regarding successful glau coma filtration surgery and 4 patients with low tension glaucoma (LTG) required low intraocular pressure (lOP) to prevent further visual field loss.
All patients underwent a complete ocular examination before and after surgery including best corrected visual acuity, lOP measurement by Eye (1995) 9, 460-466 © 1995 Royal College of Ophthalmologists Goldmann applanation tonometry, optic disc assess ment by indirect ophthalmoscopy using either the +90 dioptre or +78 dioptre Volk lens, and visual field assessment if the acuity permitted. Surgical tech nique involved the use of a limbal-based conjunctival flap, bipolar cautery to the sclera and a half-thickness rectangular scleral flap 4 mm x 4 mm created to clear cornea. A surgical sponge (Sugi Steril, John Weiss & Son Ltd) measuring 4 mm x 3 mm was soaked in a solution of 0.2 mglml MMC (Mitomycin C Kyowa powder was reconstituted in sterile water to give the final concentration). This sponge was placed under the dissected scleral flap and the conjunctival flap was also draped over the MMC soaked sponge so that only those ocular tissues in contact with the sponge were directly exposed to MMC. The sclera and the Tenon'slconjunctival surfaces were exposed to MMC for exactly 5 minutes. After this time the MMC was irrigated thoroughly with 20 ml balanced salt solution. A block of corneoscleral tissue was excised and a peripheral iridectomy performed. The scleral flap was sutured with either 10/0 nylon or 8/0 virgin silk and the conjunctiva closed with either 1010 nylon or 810 virgin silk. Post-operative medications included betametha sone 0.1% with neomycin four times a day and cyclopentolate 1 % twice daily. Visual acuity and intraocular measurements were made post-opera tively at 1 day, 1 week, 1 month, 3 months and at the latest follow-up or between these times if the clinical situation demanded. All complications were recorded.
A complete surgical success is defined as an intraocular pressure of 21 mmHg or less without any anti-glaucoma treatment. A qualified success is defined as an intraocular pressure of 21 mmHg or p -0.001
less with anti-glaucoma treatment. A failure is defined as an intraocular pressure of greater than 21 mmHg regardless of any medication.
RESULTS
The essential details of all the cases are presented in Table I . There were 9 patients with primary open angle glaucoma, 2 with chronic angle closure glaucoma, 1 with pigmentary glaucoma, 1 with panuveitis and secondary glaucoma, and 1 with pupil block glaucoma. All these patients had undergone at least one previous failed filtration procedure and were thus considered to be high risk regarding surgical success. One patient with Fuchs' heterochromic cyclitis and secondary glaucoma had undergone two previous intraocular procedures and was also included in the high-risk category being aphakic. In addition 4 patients with low tension glaucoma underwent trabeculectomy with MMC as a primary procedure. The mean follow-up period was 12.7 months with a range of 3-24 months. Fourteen eyes were followed up for 12 months or more.
The overall success is 85% (17 eyes), i.e. an lOP of 21 mmHg with or without additional anti-glaucoma medication. Complete success occurred in 70% (14 eyes) of cases, i.e. an lOP of 21 mmHg or less without any further anti-glaucoma treatment. The mean pre-operative lOP for the 16 high pressure glaucoma patients was 30.9 range 24-42 (± 10.9) mmHg with a final post-operative lOP of 15.3 range 8-20 (± 5.2) mmHg. Also the 4 patients with LTG had a mean pre-operative lOP of 17.8 range 17-18 (± 0.5) mmHg and a final post-operative lOP of 6.8 range 5-7 (± 0.7) mmHg without any medication. These results are statistically significant as outlined in Table II . Failure, defined as an intraocular pressure of >21 mmHg, was 15% (3 eyes) in this study.
Complications did arise and are summarised in Table III . Two complications occurred in patient 10 who developed a bleb leak 1 month post-operatively and a diffuse superficial punctate keratitis. The leak 
sealed off spontaneously over 2 days and the keratitis also settled with no significant effect on visual acuity and is categorised by definition a complete success. Only 1 patient developed cataract, accounting for a change in vision from 6/6 to 6/12.
Serious problems were also encountered in patients 8 and 11. In the former case there were repeated bleb leaks. The first occurred 10 months post-operatively and was treated with cyanoacrylate glue, but this procedure needed to be repeated 2 days later. Another leak occurred 10 days later at a different site on the bleb and the conjunctiva was surgically refashioned. However, the leak persisted and the trabeculectomy site was explored surgically, when it was found that in addition to the conjunctival leak there was also an area measuring approximately 3 mm x 3 mm adjacent to the original scleral flap door which was completely avascular, very thin and friable, exposing the underlying ciliary body. Clini cally this area appeared similar to scleral necrosis or scleral melting and was leaking aqueous by Siedal testing with fluorescein. The defect was repaired by creating a partial-thickness scleral flap adjacent to the area of aqueous leakage, this flap of sclera being overturned to cover the necrotic area and sutured into place with 10/0 nylon, the conjunctiva being repaired again using 8/0 vicryl. Unfortunately the conjunctiva broke down again and another leak at Ii different site on the bleb developed 10 days later. This was treated with cyanoacrylate glue and a large bandage contact lens. The eye eventually settled 12 months post-operatively with a final lOP of 19 mmHg without any glaucoma medication and an acuity of 6/9 (Figs. 1, 2b) .
The second serious complication affected patient 11. Again the major problem began with a bleb leak 4 days after filtration surgery. The lOP was 2 mmHg and the conjunctiva was refashioned. The lOP improved to 6 mmHg but the patient complained of deteriorating vision 3 months post-operatively and was found to have a hypotonous maculopathy. This was confirmed on fluorescein angiography (Fig. 3) , Another bleb leak developed at a different site from the original one with an unrecordable lOP 10 months post-operatively and the conjunctiva was surgically repaired again. The lOP did not improve but a larger bleb leak occurred. The trabeculectomy site was explored surgically and it was found that this patient also had an area clinically resembling scleral necrosis with aqueous leakage adjacent to the original flap door. This defect was again completely avascular, extremely thin and friable, exposing the ciliary body; intraoperatively for glaucoma filtration surgery. It is interesting that the 2 cases with scleral necrosis also suffered from repeated bleb leaks, and it may have been that these patients were very sensitive to the toxic effects of MMC. One of these patients (Fig. 2a) had a trabeculectomy with MMC in his fellow eye but suffered no complications. The true incidence of scleral necrosis is unknown since both cases in this study were only discovered during surgical explora tion and it may well be that other patients exhibit this phenomenon with MMC in filtration surgery. (Table IV) . We also postulate that the lOP is maintained at a low level in these particular Thus it would appear beneficial to undertake a randomised multicentre trial to assess the efficacy of both 5-FU and MMC. However, we would urge more work to be done on the action of these toxic drugs on the conjunctiva to assess suitable concentrations, exposure times and the best site of application. In addition MMC has been shown to be carcinogenic and teratogenic in rodents 4 and more research needs to be directed to the toxic effect of MMC, not only to the patient but also to the operator and assistants.
